Ad Alert

GlucoCoR

FDA warns supplement maker about unapproved diabetes treatment claims.

GlucoCoR bottle 2

The FDA recently warned the operator of a Spanish-language website selling a supplement called GlucoCoR that statements on the site illegally market GlucoCoR as a drug intended for use in the cure, mitigation, treatment, or prevention of disease. The claims included:

  • “Promote healthy glucose levels”
  • “Promote … tissue repair”
  • “Helps maintain adequate levels of blood sugar” (also on product packaging)
  • “Attends the biochemical origin of the disease”
  • “Treatment for Diabetes 1 and 2 diabetes GlucoCor”

The agency, in its warning letter, also cited problem claims appearing on the Puerto Rican company’s Facebook page.

RELATED: The Diabetes Solution Kit

Remember, readers, marketing supplements as having the ability to treat, cure, alleviate the symptoms of, or prevent developing diseases and disorders is simply not permitted by law. If a supplement really could do all that, then it would be a drug subject to rigorous study and testing to gain FDA approval.

Find more of our coverage on supplements here.


Our Ad Alerts are not just about false and deceptive marketing issues, but may also be about ads that, although not necessarily deceptive, should be viewed with caution. Ad Alerts can also be about single issues and may not include a comprehensive list of all marketing issues relating to the brand discussed.


You Might Be Interested In

UNBS CBD Gummies

Ad Alert

UNBS CBD Gummies

Spam email leads to a fake endorsement from Dr. Oz, among other celebrities.